CD14 and myelodysplastic syndrome: The median fluorescence intensity (MFI) of CD14+ cells from the bone marrow in the control group, LR-MDS group, and HR-MDS group was 639.05 ± 359.78, 501.43 ± 374.44, and 458.26 ± 306.72, respectively.